(0.32%) 5 116.31 points
(0.30%) 38 355 points
(0.38%) 15 988 points
(-0.95%) $83.05
(5.36%) $2.03
(0.33%) $2 354.90
(0.47%) $27.67
(4.16%) $960.45
(-0.27%) $0.932
(-0.45%) $10.98
(-0.58%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide...
Stats | |
---|---|
本日の出来高 | 522 109 |
平均出来高 | 956 988 |
時価総額 | 294.19M |
EPS | $-0.990 ( 2022-05-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.74 |
ATR14 | $0.238 (6.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-04-01 | Barthelemy Nicolas | Sell | 20 993 | Stock Option (Right to Buy) |
2022-03-31 | Barthelemy Nicolas | Sell | 5 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 2 transactions |
Buy: 0 | Sell: 25 993 |
ボリューム 相関
Fluidigm Corp 相関
10 最も正の相関 | |
---|---|
NKSH | 0.917 |
PBHC | 0.909 |
ATLO | 0.909 |
BOTJ | 0.898 |
FFNW | 0.897 |
CVLY | 0.892 |
VLYPP | 0.892 |
NWFL | 0.892 |
OPI | 0.889 |
TKNO | 0.887 |
10 最も負の相関 | |
---|---|
ALR | -0.885 |
SMED | -0.878 |
SOVO | -0.868 |
VERX | -0.863 |
MOTNU | -0.863 |
PODD | -0.861 |
IMRX | -0.861 |
LFST | -0.861 |
VIVO | -0.853 |
MDLZ | -0.846 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Fluidigm Corp 相関 - 通貨/商品
Fluidigm Corp 財務諸表
Annual | 2023 |
収益: | $106.34M |
総利益: | $50.45M (47.44 %) |
EPS: | $-0.940 |
FY | 2023 |
収益: | $106.34M |
総利益: | $50.45M (47.44 %) |
EPS: | $-0.940 |
FY | 2022 |
収益: | $97.95M |
総利益: | $37.05M (37.83 %) |
EPS: | $-2.43 |
FY | 2021 |
収益: | $130.58M |
総利益: | $69.37M (53.13 %) |
EPS: | $-0.776 |
Financial Reports:
No articles found.
Fluidigm Corp
Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。